First Trust Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-95,609
Closed -$774K 2356
2023
Q1
$774K Buy
95,609
+34,658
+57% +$278K ﹤0.01% 2032
2022
Q4
$383K Sell
60,951
-224,259
-79% -$1.57M ﹤0.01% 2263
2022
Q3
$1.97M Buy
+285,210
New +$1.98M ﹤0.01% 1679
2021
Q4
Sell
-40,540
Closed -$1.13M 2516
2021
Q3
$1.13M Buy
40,540
+1,599
+4% +$45.3K ﹤0.01% 1992
2021
Q2
$1.14M Buy
+38,941
New +$1.18M ﹤0.01% 2023
2017
Q2
Sell
-41,645
Closed -$459K 2372
2017
Q1
$459K Buy
+41,645
New +$573K ﹤0.01% 2113
2015
Q4
Sell
-2,802
Closed -$500K 2242
2015
Q3
$500K Buy
+2,802
New +$653K ﹤0.01% 1967

Other funds holding BHC

First Trust Advisors's BHC Position: Q2 2023 in Review

First Trust Advisors sold out of Bausch Health (BHC) in Q2 2023, closing a stake of 95,609 shares — an estimated $774K sold.

First Trust Advisors first reported a position in BHC in Q3 2015 and held it in 7 quarters. The position peaked at $1.97M in Q3 2022. 232 funds tracked by Wall St. Rank hold BHC as of Q2 2023.

  • First Trust Advisors reported no remaining Bausch Health position as of Q2 2023 after selling out during the quarter.
  • First Trust Advisors sold 95,609 Bausch Health shares in Q2 2023, an estimated $774K.
  • First Trust Advisors first reported a position in Bausch Health in Q3 2015 and held it in 7 quarters.
  • First Trust Advisors's Bausch Health position peaked at $1.97M in Q3 2022.
  • 232 funds tracked by Wall St. Rank held Bausch Health as of Q2 2023.

Based on First Trust Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.